EV/FCF Ratio: 30.49x
Is the EV/FCF ratio high or low?
The EV/FCF ratio of 30.49x is in line with its 5-year average of 32.14x, around the middle of its 5-year range (15.29x–54.28x).
As of Saturday, June 27, 2026. 13.92% below its 12-month average of 35.42x.
NRC EV/FCF Ratio Chart
NRC Average EV/FCF Ratio Chart
NRC Current vs Average EV/FCF Ratio Chart
NRC EV/FCF Ratio Metrics
EV/FCF RATIO
30.49x
EV/FCF RATIO AVG TTM
35.42x
EV/FCF RATIO AVG 3Y
33.88x
EV/FCF RATIO AVG 5Y
32.14x
EV/FCF RATIO AVG 10Y
33.21x
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-13.92%
CURRENT VS 3Y AVG
-10.02%
CURRENT VS 5Y AVG
-5.14%
CURRENT VS 10Y AVG
-8.20%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
NRC Competitors' EV/FCF Ratio
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| National Research Corporation (NRC) | $468.99M | 30.49x | 35.42x | 33.88x | 32.14x |
| Shoulder Innovations, Inc. (SI)vs › | $472.62M | N/A | N/A | N/A | N/A |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.51B | 7.13x | 7.26x | 9.61x | 16.61x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | 41.75x | 41.70x | 32.79x | 28.47x |
| TransMedics Group, Inc. (TMDX)vs › | $2.37B | 19.02x | 105.17x | 105.17x | 105.17x |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.56B | 110.49x | 84.57x | 71.89x | 71.89x |
| Oscar Health, Inc. (OSCR)vs › | $7.72B | 1.95x | 2.32x | 4.12x | 4.36x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.13B | 25.14x | 25.17x | 42.57x | 51.02x |
| Universal Health Services, Inc. (UHS)vs › | $9.12B | 15.66x | 19.10x | 27.34x | 59.24x |
Cash Flow Valuation Comparison
EV/FCF
30.5x
P/FCF
26.2x
FCF Yield
3.82%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
- EV/FCF accounts for debt and cash through enterprise value
- P/FCF only considers equity value
- EV/FCF can be compared across companies with different debt levels
- Both measure how the market values cash generation
EV/FCF Ratio Formula & Definition
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EV/FCF Ratio FAQ
- What is the EV/FCF ratio for National Research Corporation (NRC)?
- The EV/FCF ratio for NRC stock is 30.49x.
- Is National Research Corporation's EV/FCF ratio high or low?
- The EV/FCF ratio of 30.49x is in line with its 5-year average of 32.14x, around the middle of its 5-year range (15.29x–54.28x).
- What is the TTM average EV/FCF ratio for National Research Corporation (NRC)?
- The TTM average EV/FCF ratio for NRC stock is 35.42x.
- What is the 3Y average EV/FCF ratio for National Research Corporation (NRC)?
- The 3Y average EV/FCF ratio for NRC stock is 33.88x.
- What is the 5Y average EV/FCF ratio for National Research Corporation (NRC)?
- The 5Y average EV/FCF ratio for NRC stock is 32.14x.
- What is the 10Y average EV/FCF ratio for National Research Corporation (NRC)?
- The 10Y average EV/FCF ratio for NRC stock is 33.21x.
NRC EV/FCF Ratio History
| DATE | EV/FCF RATIO |
|---|---|
| 2026-06-26 | 30.49x |
| 2026-06-25 | 30.15x |
| 2026-06-24 | 30.35x |
| 2026-06-23 | 29.52x |
| 2026-06-22 | 28.83x |
| 2026-06-18 | 27.64x |
| 2026-06-17 | 26.64x |
| 2026-06-16 | 27.55x |
| 2026-06-15 | 27.35x |
| 2026-06-12 | 27.95x |
| 2026-06-11 | 27.95x |
| 2026-06-10 | 31.08x |
| 2026-06-09 | 29.16x |
| 2026-06-08 | 28.63x |
| 2026-06-05 | 28.39x |
| 2026-06-04 | 29.16x |
| 2026-06-03 | 28.27x |
| 2026-06-02 | 28.96x |
| 2026-06-01 | 29.79x |
| 2026-05-29 | 28.88x |
| 2026-05-28 | 29.05x |
| 2026-05-27 | 28.38x |
| 2026-05-26 | 28.27x |
| 2026-05-22 | 28.32x |
| 2026-05-21 | 28.27x |
| 2026-05-20 | 28.54x |
| 2026-05-19 | 27.90x |
| 2026-05-18 | 27.89x |
| 2026-05-15 | 27.74x |
| 2026-05-14 | 28.13x |
| 2026-05-13 | 27.80x |
| 2026-05-12 | 28.45x |
| 2026-05-11 | 27.85x |
| 2026-05-08 | 27.90x |
| 2026-05-07 | 27.88x |
| 2026-05-06 | 26.78x |
| 2026-05-05 | 30.71x |
| 2026-05-04 | 29.99x |
| 2026-05-01 | 28.87x |
| 2026-04-30 | 27.56x |
| 2026-04-29 | 27.67x |
| 2026-04-28 | 28.08x |
| 2026-04-27 | 28.46x |
| 2026-04-24 | 28.62x |
| 2026-04-23 | 28.65x |
| 2026-04-22 | 29.00x |
| 2026-04-21 | 28.55x |
| 2026-04-20 | 29.94x |
| 2026-04-17 | 29.73x |
| 2026-04-16 | 29.16x |
| 2026-04-15 | 29.47x |
| 2026-04-14 | 28.36x |
| 2026-04-13 | 28.05x |
| 2026-04-10 | 27.58x |
| 2026-04-09 | 28.37x |
| 2026-04-08 | 28.66x |
| 2026-04-07 | 28.36x |
| 2026-04-06 | 28.76x |
| 2026-04-02 | 28.53x |
| 2026-04-01 | 28.77x |
| 2026-03-31 | 28.28x |
| 2026-03-30 | 28.50x |
| 2026-03-27 | 28.48x |
| 2026-03-26 | 29.02x |
| 2026-03-25 | 28.55x |
| 2026-03-24 | 28.91x |
| 2026-03-23 | 29.01x |
| 2026-03-20 | 28.75x |
| 2026-03-19 | 28.73x |
| 2026-03-18 | 29.09x |
| 2026-03-17 | 29.31x |
| 2026-03-16 | 28.86x |
| 2026-03-13 | 27.64x |
| 2026-03-12 | 27.61x |
| 2026-03-11 | 26.93x |
| 2026-03-10 | 27.29x |
| 2026-03-09 | 25.49x |
| 2026-03-06 | 24.97x |
| 2026-03-05 | 24.20x |
| 2026-03-04 | 32.20x |
| 2026-03-03 | 32.73x |
| 2026-03-02 | 33.62x |
| 2026-02-27 | 32.76x |
| 2026-02-26 | 32.82x |
| 2026-02-25 | 31.83x |
| 2026-02-24 | 30.98x |
| 2026-02-23 | 31.00x |
| 2026-02-20 | 33.27x |
| 2026-02-19 | 30.90x |
| 2026-02-18 | 30.66x |
| 2026-02-17 | 30.08x |
| 2026-02-13 | 30.18x |
| 2026-02-12 | 31.64x |
| 2026-02-11 | 33.42x |
| 2026-02-10 | 35.00x |
| 2026-02-09 | 36.57x |
| 2026-02-06 | 37.68x |
| 2026-02-05 | 37.66x |
| 2026-02-04 | 36.38x |
| 2026-02-03 | 40.95x |
| 2026-02-02 | 49.27x |
| 2026-01-30 | 46.24x |
| 2026-01-29 | 45.67x |
| 2026-01-28 | 45.20x |
| 2026-01-27 | 46.25x |
| 2026-01-26 | 47.15x |
| 2026-01-23 | 47.65x |
| 2026-01-22 | 49.48x |
| 2026-01-21 | 50.40x |
| 2026-01-20 | 49.25x |
| 2026-01-16 | 49.89x |
| 2026-01-15 | 48.10x |
| 2026-01-14 | 47.21x |
| 2026-01-13 | 47.28x |
| 2026-01-12 | 46.41x |
| 2026-01-09 | 45.03x |
| 2026-01-08 | 44.58x |
| 2026-01-07 | 43.44x |
| 2026-01-06 | 44.21x |
| 2026-01-05 | 43.24x |
| 2026-01-02 | 41.74x |
| 2025-12-31 | 43.18x |
| 2025-12-30 | 42.95x |
| 2025-12-29 | 43.57x |
| 2025-12-26 | 42.97x |
| 2025-12-24 | 43.26x |
| 2025-12-23 | 43.65x |
| 2025-12-22 | 43.40x |
| 2025-12-19 | 43.05x |
| 2025-12-18 | 44.21x |
| 2025-12-17 | 42.93x |
| 2025-12-16 | 42.52x |
| 2025-12-15 | 41.69x |
| 2025-12-12 | 40.99x |
| 2025-12-11 | 40.56x |
| 2025-12-10 | 39.61x |
| 2025-12-09 | 37.88x |
| 2025-12-08 | 37.51x |
| 2025-12-05 | 37.55x |
| 2025-12-04 | 38.42x |
| 2025-12-03 | 38.13x |
| 2025-12-02 | 38.19x |
| 2025-12-01 | 39.33x |
| 2025-11-28 | 39.72x |
| 2025-11-26 | 40.27x |
| 2025-11-25 | 41.73x |
| 2025-11-24 | 40.36x |
| 2025-11-21 | 41.03x |
| 2025-11-20 | 38.98x |
| 2025-11-19 | 38.40x |
| 2025-11-18 | 37.90x |
| 2025-11-17 | 37.84x |
| 2025-11-14 | 36.30x |
| 2025-11-13 | 36.90x |
| 2025-11-12 | 36.69x |
| 2025-11-11 | 35.72x |
| 2025-11-10 | 34.84x |
| 2025-11-07 | 35.27x |
| 2025-11-06 | 43.21x |
| 2025-11-05 | 42.55x |
| 2025-11-04 | 41.84x |
| 2025-11-03 | 40.54x |
| 2025-10-31 | 40.81x |
| 2025-10-30 | 40.18x |
| 2025-10-29 | 41.03x |
| 2025-10-28 | 40.54x |
| 2025-10-27 | 36.07x |
| 2025-10-24 | 36.66x |
| 2025-10-23 | 36.66x |
| 2025-10-22 | 37.24x |
| 2025-10-21 | 37.71x |
| 2025-10-20 | 37.32x |
| 2025-10-17 | 36.53x |
| 2025-10-16 | 36.70x |
| 2025-10-15 | 36.14x |
| 2025-10-14 | 36.31x |
| 2025-10-13 | 36.22x |
| 2025-10-10 | 36.22x |
| 2025-10-09 | 36.80x |
| 2025-10-08 | 37.29x |
| 2025-10-07 | 37.54x |
| 2025-10-06 | 37.66x |
| 2025-10-03 | 38.00x |
| 2025-10-02 | 38.61x |
| 2025-10-01 | 38.71x |
| 2025-09-30 | 39.39x |
| 2025-09-29 | 39.37x |
| 2025-09-26 | 40.66x |
| 2025-09-25 | 42.01x |
| 2025-09-24 | 43.72x |
| 2025-09-23 | 44.01x |
| 2025-09-22 | 45.36x |
| 2025-09-19 | 44.33x |
| 2025-09-18 | 46.99x |
| 2025-09-17 | 47.04x |
| 2025-09-16 | 47.41x |
| 2025-09-15 | 47.75x |
| 2025-09-12 | 47.29x |
| 2025-09-11 | 47.75x |
| 2025-09-10 | 46.99x |
| 2025-09-09 | 47.60x |
| 2025-09-08 | 46.65x |
| 2025-09-05 | 45.80x |
| 2025-09-04 | 44.72x |
| 2025-09-03 | 44.16x |
| 2025-09-02 | 44.99x |
| 2025-08-29 | 44.06x |
| 2025-08-28 | 43.96x |
| 2025-08-27 | 45.99x |
| 2025-08-26 | 45.75x |
| 2025-08-25 | 45.45x |
| 2025-08-22 | 45.72x |
| 2025-08-21 | 43.62x |
| 2025-08-20 | 46.58x |
| 2025-08-19 | 47.68x |
| 2025-08-18 | 46.06x |
| 2025-08-15 | 45.58x |
| 2025-08-14 | 44.82x |
| 2025-08-13 | 46.21x |
| 2025-08-12 | 46.11x |
| 2025-08-11 | 45.04x |
| 2025-08-08 | 45.06x |
| 2025-08-07 | 26.79x |
| 2025-08-06 | 25.98x |
| 2025-08-05 | 25.44x |
| 2025-08-04 | 25.21x |
| 2025-08-01 | 23.55x |
| 2025-07-31 | 23.42x |
| 2025-07-30 | 23.62x |
| 2025-07-29 | 24.59x |
| 2025-07-28 | 25.64x |
| 2025-07-25 | 25.56x |
| 2025-07-24 | 25.91x |
| 2025-07-23 | 26.85x |
| 2025-07-22 | 25.98x |
| 2025-07-21 | 25.81x |
| 2025-07-18 | 26.07x |
| 2025-07-17 | 27.19x |
| 2025-07-16 | 27.19x |
| 2025-07-15 | 27.42x |
| 2025-07-14 | 27.85x |
| 2025-07-11 | 28.74x |
| 2025-07-10 | 29.22x |
| 2025-07-09 | 29.94x |
| 2025-07-08 | 30.14x |
| 2025-07-07 | 29.53x |
| 2025-07-03 | 30.36x |
| 2025-07-02 | 29.64x |
| 2025-07-01 | 29.84x |
| 2025-06-30 | 30.04x |
| 2025-06-27 | 29.84x |
| 2025-06-26 | 29.10x |
| 2025-06-25 | 30.10x |
| 2025-06-24 | 30.71x |
| 2025-06-23 | 30.34x |
| 2025-06-20 | 29.65x |
| 2025-06-18 | 30.08x |
| 2025-06-17 | 29.99x |
| 2025-06-16 | 29.77x |
| 2025-06-13 | 28.87x |
Showing the most recent 260 of 3,293 data points. The chart above shows the full history.
Related Metrics
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green